22nd Century Group, Inc. (NASDAQ:XXII) Short Interest Down 63.8% in January

22nd Century Group, Inc. (NASDAQ:XXIIGet Free Report) was the recipient of a large decrease in short interest in the month of January. As of January 31st, there was short interest totalling 178,800 shares, a decrease of 63.8% from the January 15th total of 493,400 shares. Currently, 11.5% of the company’s stock are sold short. Based on an average daily volume of 875,300 shares, the short-interest ratio is presently 0.2 days.

Wall Street Analysts Forecast Growth

XXII has been the subject of several research reports. Weiss Ratings reaffirmed a “sell (e)” rating on shares of 22nd Century Group in a research report on Saturday, February 1st. StockNews.com cut shares of 22nd Century Group from a “hold” rating to a “sell” rating in a research report on Tuesday, December 31st.

View Our Latest Stock Analysis on XXII

22nd Century Group Price Performance

Shares of XXII opened at $3.09 on Friday. The company has a 50 day moving average price of $5.63 and a 200-day moving average price of $26.49. 22nd Century Group has a fifty-two week low of $3.01 and a fifty-two week high of $581.85. The stock has a market capitalization of $5.31 million, a PE ratio of 0.00 and a beta of 1.57. The company has a debt-to-equity ratio of 1.59, a quick ratio of 0.93 and a current ratio of 1.09.

22nd Century Group (NASDAQ:XXIIGet Free Report) last posted its earnings results on Tuesday, November 12th. The biotechnology company reported ($72.90) EPS for the quarter. The company had revenue of $5.95 million for the quarter.

Institutional Investors Weigh In On 22nd Century Group

An institutional investor recently bought a new position in 22nd Century Group stock. Anson Funds Management LP bought a new stake in shares of 22nd Century Group, Inc. (NASDAQ:XXIIFree Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned about 6.77% of 22nd Century Group as of its most recent SEC filing. 18.06% of the stock is owned by hedge funds and other institutional investors.

22nd Century Group Company Profile

(Get Free Report)

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.

Read More

Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.